Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Receivables - Other (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Receivables - Other for 12 consecutive years, with $8.1 million as the latest value for Q1 2026.

  • Quarterly Receivables - Other rose 9.03% to $8.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Jan 2026, up 9.03% year-over-year, with the annual reading at $8.1 million for FY2026, 9.03% up from the prior year.
  • Receivables - Other for Q1 2026 was $8.1 million at Usana Health Sciences, up from $7.4 million in the prior quarter.
  • The five-year high for Receivables - Other was $8.1 million in Q1 2026, with the low at $5.6 million in Q1 2022.
  • Average Receivables - Other over 4 years is $6.8 million, with a median of $6.8 million recorded in 2023.
  • The sharpest move saw Receivables - Other decreased 10.68% in 2022, then rose 20.2% in 2024.
  • Over 4 years, Receivables - Other stood at $5.6 million in 2022, then increased by 10.53% to $6.2 million in 2023, then grew by 20.2% to $7.4 million in 2024, then grew by 9.03% to $8.1 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $8.1 million, $7.4 million, and $6.2 million for Q1 2026, Q4 2024, and Q4 2023 respectively.